ASTM-F2901 Standard Guide for Selecting Tests to Evaluate Potential Neurotoxicity of Medical Devices

ASTM-F2901 - 2019 EDITION - CURRENT
Show Complete Document History

Document Center Inc. is an authorized dealer of ASTM standards.
The following bibliographic material is provided to assist you with your purchasing decision:

Standard Guide for Selecting Tests to Evaluate Potential Neurotoxicity of Medical Devices
ORDER

Price:

$48.00        

Changes from the previous issue

A redline edition is available for this document, with all changes visible. Ask Document Center Inc. for more information.

Scope

1.1 Medical devices may cause adverse effects on the structure and/or function of the nervous system. In this guide, these adverse effects are defined as neurotoxicity. This guide provides background information and recommendations on methods for neurotoxicity testing. This guide should be used with Practice F748, and may be helpful where neurotoxicity testing is needed to evaluate medical devices that contact central and/or peripheral nervous system tissue or cerebral spinal fluid (CSF).

Note 1: The results of these in vitro and in vivo tests may not correspond to actual human response.

1.2 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of regulatory limitations prior to use.

1.3 This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.

Significance and Use

4.1 The objective of this guide is to recommend a panel of biological tests that can be used in addition to the testing recommended in Practice F748. This guide is designed to detect neurotoxicity caused by medical devices that contact nervous tissue.

4.2 The testing recommendations should be considered for new materials, established materials with different manufacturing methods that could affect nervous tissue response, or materials used in new nervous tissue applications.

4.3 Chemical characterization can be used to evaluate similarity for materials with a history of clinical use in a similar nervous tissue application.

Keywords

astrogliosis; biocompatibility; microglia; myelinopathy; neurodegeneration; neurotoxicity;; ICS Number Code 11.040.01 (Medical equipment in general)

To find similar documents by ASTM Volume:

13.02 (Emergency Medical Services; Search and Rescue; Anesthetic and Respiratory Equipment)

To find similar documents by classification:

11.040.01 (Medical equipment in general)

This document comes with our free Notification Service, good for the life of the document.

This document is available in either Paper or PDF format.

Document Number

ASTM-F2901-19

Revision Level

2019 EDITION

Status

Current

Modification Type

Revision

Publication Date

March 1, 2019

Document Type

Guide

Page Count

5 pages

Committee Number

F04.16